Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

Services Hospital, Lahore

Status and phase: Completed; Phase 4

Conditions: Hemorrhoids

Treatments: Drug: CDobi; Drug: Flavonoids

Study type: Interventional

Funder types: Other

Identifiers

NCT02782455

DD

Details and patient eligibility

About

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

Enrollment: 100 patients

Sex: All

Ages: 13 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Grade I and Grade II hemorrhoids

Exclusion criteria

• CLD
• colorectal/ anorectal Malignancy
• self medication
• local Quack Hakeem medication
• pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

100 participants in 2 patient groups

CDobi

Experimental group

Description:

Calcium dobesylate is given in this group

Treatment:

Drug: CDobi

Flavono

Active Comparator group

Description:

Flavonoids are given in this group

Treatment:

Drug: Flavonoids